AlloMek
AlloMek is working on a small molecule based therapeutics for rare diseases. AlloMek Team: Uday Khire, Ph.D. MBA Co-Founder and CEO
Read MoreCytosolix
Cytosolix is developing a small-molecule tumor targeted chemotherapy platform. Cytosolix Team: John C. Deacon, Ph.D., Founder and President
Read More